Polatuzumab Vedotin
An antibody-drug conjugate that combines a targeted antibody with a powerful chemotherapy agent to treat certain types of aggressive B-cell lymphoma. The antibody portion seeks out and attaches to a protein found on lymphoma cells, delivering the chemotherapy directly to the cancer cells to kill them while limiting harm to healthy tissue.
Area Terapeutik
Mekanisme Kerja
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
An antibody-drug conjugate that combines a targeted antibody with a powerful chemotherapy agent to treat certain types of aggressive B-cell lymphoma. The antibody portion seeks out and attaches to a protein found on lymphoma cells, delivering the chemotherapy directly to the cancer cells to kill them while limiting harm to healthy tissue.
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
Yes, Polatuzumab Vedotin is an approved drug. It has reached clinical phase 4. It is classified as a Antibody drug conjugate.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3301582. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="polatuzumab-vedotin"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/polatuzumab-vedotin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/polatuzumab-vedotin/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/polatuzumab-vedotin/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="polatuzumab-vedotin"></drugfyi-drug>